Article Versions Notes

Sekino Y, Pham QT, Kobatake K, Kitano H, Ikeda K, Goto K, Hayashi T, Nakahara H, Sentani K, Oue N, et al. KIFC1 Is Associated with Basal Type, Cisplatin Resistance, PD-L1 Expression and Poor Prognosis in Bladder Cancer. Journal of Clinical Medicine. 2021; 10(21):4837. https://doi.org/10.3390/jcm10214837

Sekino, Yohei, Quoc Thang Pham, Kohei Kobatake, Hiroyuki Kitano, Kenichiro Ikeda, Keisuke Goto, Tetsutaro Hayashi, Hikaru Nakahara, Kazuhiro Sentani, Naohide Oue, and et al. 2021. "KIFC1 Is Associated with Basal Type, Cisplatin Resistance, PD-L1 Expression and Poor Prognosis in Bladder Cancer" Journal of Clinical Medicine 10, no. 21: 4837. https://doi.org/10.3390/jcm10214837

Sekino, Y., Pham, Q. T., Kobatake, K., Kitano, H., Ikeda, K., Goto, K., Hayashi, T., Nakahara, H., Sentani, K., Oue, N., Yasui, W., Teishima, J., & Hinata, N. (2021). KIFC1 Is Associated with Basal Type, Cisplatin Resistance, PD-L1 Expression and Poor Prognosis in Bladder Cancer. Journal of Clinical Medicine, 10(21), 4837. https://doi.org/10.3390/jcm10214837